vs
Organogenesis Holdings Inc.(ORGO)与Revolve Group, Inc.(RVLV)财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Organogenesis Holdings Inc.的1.4倍($324.4M vs $225.6M),Organogenesis Holdings Inc.净利率更高(19.4% vs 5.7%,领先13.7%),Organogenesis Holdings Inc.同比增速更快(78.1% vs 10.4%),Organogenesis Holdings Inc.自由现金流更多($34.8M vs $-13.3M),过去两年Organogenesis Holdings Inc.的营收复合增速更高(43.2% vs 9.5%)
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团,专注于创作演出政治题材和莎士比亚系列戏剧作品,由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
ORGO vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.4倍
$225.6M
营收增速更快
ORGO
高出67.7%
10.4%
净利率更高
ORGO
高出13.7%
5.7%
自由现金流更多
ORGO
多$48.1M
$-13.3M
两年增速更快
ORGO
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $225.6M | $324.4M |
| 净利润 | $43.7M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | 28.1% | 6.3% |
| 净利率 | 19.4% | 5.7% |
| 营收同比 | 78.1% | 10.4% |
| 净利润同比 | 469.5% | 50.4% |
| 每股收益(稀释后) | $0.31 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ORGO
RVLV
| Q4 25 | $225.6M | $324.4M | ||
| Q3 25 | $150.9M | $295.6M | ||
| Q2 25 | $101.0M | $309.0M | ||
| Q1 25 | $86.7M | $296.7M | ||
| Q4 24 | $126.7M | $293.7M | ||
| Q3 24 | $115.2M | $283.1M | ||
| Q2 24 | $130.2M | $282.5M | ||
| Q1 24 | $110.0M | $270.6M |
净利润
ORGO
RVLV
| Q4 25 | $43.7M | $18.6M | ||
| Q3 25 | $21.6M | $21.2M | ||
| Q2 25 | $-9.4M | $10.2M | ||
| Q1 25 | $-18.8M | $11.8M | ||
| Q4 24 | $7.7M | $12.3M | ||
| Q3 24 | $12.3M | $11.0M | ||
| Q2 24 | $-17.0M | $15.4M | ||
| Q1 24 | $-2.1M | $10.9M |
毛利率
ORGO
RVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | 72.6% | 52.0% | ||
| Q4 24 | 75.5% | 52.5% | ||
| Q3 24 | 76.7% | 51.2% | ||
| Q2 24 | 77.6% | 54.0% | ||
| Q1 24 | 73.9% | 52.3% |
营业利润率
ORGO
RVLV
| Q4 25 | 28.1% | 6.3% | ||
| Q3 25 | 13.7% | 7.1% | ||
| Q2 25 | -12.5% | 5.8% | ||
| Q1 25 | -30.9% | 5.0% | ||
| Q4 24 | 8.1% | 3.9% | ||
| Q3 24 | 5.4% | 5.0% | ||
| Q2 24 | -10.7% | 5.8% | ||
| Q1 24 | -3.5% | 3.4% |
净利率
ORGO
RVLV
| Q4 25 | 19.4% | 5.7% | ||
| Q3 25 | 14.3% | 7.2% | ||
| Q2 25 | -9.3% | 3.3% | ||
| Q1 25 | -21.7% | 4.0% | ||
| Q4 24 | 6.1% | 4.2% | ||
| Q3 24 | 10.7% | 3.9% | ||
| Q2 24 | -13.1% | 5.4% | ||
| Q1 24 | -1.9% | 4.0% |
每股收益(稀释后)
ORGO
RVLV
| Q4 25 | $0.31 | $0.27 | ||
| Q3 25 | $0.11 | $0.29 | ||
| Q2 25 | $-0.10 | $0.14 | ||
| Q1 25 | $-0.17 | $0.16 | ||
| Q4 24 | $0.05 | $0.18 | ||
| Q3 24 | $0.09 | $0.15 | ||
| Q2 24 | $-0.13 | $0.21 | ||
| Q1 24 | $-0.02 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $300.1M | $512.5M |
| 总资产 | $598.7M | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ORGO
RVLV
| Q4 25 | $93.7M | $292.3M | ||
| Q3 25 | $63.7M | $315.4M | ||
| Q2 25 | $73.1M | $310.7M | ||
| Q1 25 | $110.0M | $300.8M | ||
| Q4 24 | $135.6M | $256.6M | ||
| Q3 24 | $94.3M | $252.8M | ||
| Q2 24 | $89.9M | $244.7M | ||
| Q1 24 | $88.6M | $273.4M |
总债务
ORGO
RVLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | — |
股东权益
ORGO
RVLV
| Q4 25 | $300.1M | $512.5M | ||
| Q3 25 | $255.1M | $490.2M | ||
| Q2 25 | $233.2M | $468.6M | ||
| Q1 25 | $242.9M | $453.4M | ||
| Q4 24 | $262.9M | $437.8M | ||
| Q3 24 | $278.5M | $420.8M | ||
| Q2 24 | $263.5M | $405.8M | ||
| Q1 24 | $278.0M | $389.9M |
总资产
ORGO
RVLV
| Q4 25 | $598.7M | $765.0M | ||
| Q3 25 | $509.8M | $751.3M | ||
| Q2 25 | $461.1M | $722.9M | ||
| Q1 25 | $467.4M | $713.9M | ||
| Q4 24 | $497.9M | $665.5M | ||
| Q3 24 | $446.3M | $670.9M | ||
| Q2 24 | $443.2M | $657.8M | ||
| Q1 24 | $458.5M | $650.0M |
负债/权益比
ORGO
RVLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $39.4M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | $-13.3M |
| 自由现金流率自由现金流/营收 | 15.4% | -4.1% |
| 资本支出强度资本支出/营收 | 2.1% | 1.0% |
| 现金转化率经营现金流/净利润 | 0.90× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $-24.5M | $48.0M |
8季度趋势,按日历期对齐
经营现金流
ORGO
RVLV
| Q4 25 | $39.4M | $-10.2M | ||
| Q3 25 | $3.1M | $11.8M | ||
| Q2 25 | $-32.9M | $12.6M | ||
| Q1 25 | $-19.9M | $45.1M | ||
| Q4 24 | $10.9M | $3.9M | ||
| Q3 24 | $8.7M | $9.1M | ||
| Q2 24 | $4.7M | $-24.7M | ||
| Q1 24 | $-10.2M | $38.4M |
自由现金流
ORGO
RVLV
| Q4 25 | $34.8M | $-13.3M | ||
| Q3 25 | $844.0K | $7.5M | ||
| Q2 25 | $-36.5M | $10.4M | ||
| Q1 25 | $-23.6M | $43.4M | ||
| Q4 24 | $7.6M | $2.1M | ||
| Q3 24 | $6.1M | $8.0M | ||
| Q2 24 | $2.9M | $-25.7M | ||
| Q1 24 | $-12.4M | $36.7M |
自由现金流率
ORGO
RVLV
| Q4 25 | 15.4% | -4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | -36.1% | 3.4% | ||
| Q1 25 | -27.2% | 14.6% | ||
| Q4 24 | 6.0% | 0.7% | ||
| Q3 24 | 5.3% | 2.8% | ||
| Q2 24 | 2.2% | -9.1% | ||
| Q1 24 | -11.3% | 13.5% |
资本支出强度
ORGO
RVLV
| Q4 25 | 2.1% | 1.0% | ||
| Q3 25 | 1.5% | 1.5% | ||
| Q2 25 | 3.6% | 0.7% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 2.7% | 0.6% | ||
| Q3 24 | 2.2% | 0.4% | ||
| Q2 24 | 1.4% | 0.4% | ||
| Q1 24 | 2.0% | 0.6% |
现金转化率
ORGO
RVLV
| Q4 25 | 0.90× | -0.55× | ||
| Q3 25 | 0.14× | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | 1.43× | 0.32× | ||
| Q3 24 | 0.71× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |